Alere Medical Inc and Resolution Health Inc are working together to expand Alere's disease management capabilities to identify patients and intervention opportunities. Resolution Health's technology will be used to accelerate claims analysis for pharmacy, medical, laboratory, and other departments to facilitate the identification and enrollment of patients into one of Alere's disease management programs. In January 2006, the company launched the new capabilities with PacifiCare Health Systems.
As part of the agreement, Alere will also incorporate Resolution Health's Direct-to-Member personalized interventions with its disease management programs for some of PacifiCare's national accounts, driving member compliance with evidence-based guidelines and PacifiCare's drug formulary by up to 60%, according to studies of Resolution Health's personalized member communications.
"Active enrollment and engagement of patients into result-driven disease management programs are key components of health care today," said Gordon Norman, MD, MBA, chief medical officer for Alere. "Resolution Health's technology is a great complement to our existing capabilities and will further our ability to provide consistent, demonstrable results on behalf of our customers."
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs